scholarly journals A Phase 2a study evaluating the safety, tolerability, pharmacokinetics, and central nervous system activity of CY6463 when administered to participants with Alzheimer’s disease with vascular pathology

2021 ◽  
Vol 17 (S9) ◽  
Author(s):  
Chad Glasser ◽  
Jennifer Chickering ◽  
Phebe Wilson ◽  
Emily Florine ◽  
Chris Winrow ◽  
...  
Phytomedicine ◽  
2002 ◽  
Vol 9 (6) ◽  
pp. 501-507 ◽  
Author(s):  
M.H. Al-Yousuf ◽  
B.H. Ali ◽  
A.K. Bashir ◽  
M.O.M. Tanira ◽  
G. Blunden

2018 ◽  
Vol 10 (4) ◽  
pp. 339
Author(s):  
Akash Ved ◽  
Amresh Gupta ◽  
Om Prakash ◽  
AjayKumar Singh Rawat

Sign in / Sign up

Export Citation Format

Share Document